HealthCare Global Enterprises EV/EBITDA
Qual é o EV/EBITDA de HealthCare Global Enterprises?
O EV/EBITDA de HealthCare Global Enterprises Limited é 18.18
Qual é a definição de EV/EBITDA?
EV/EBITDA é o valor da empresa dividido pelo lucro antes de juros, impostos, depreciação e amortização. É uma medida de quão cara é uma ação e é mais frequentemente válida para comparações entre empresas do que da relação entre preço e lucro. Ele mede o preço (na forma de valor da empresa) que um investidor paga em benefício do fluxo de caixa da empresa (na forma de EBITDA).
Price to earnings ratios are impacted by a company's choice of capital structure - companies which raise money via debt will have lower P/Es (and therefore look cheaper) than companies that raise an equivalent amount of money by issuing shares, even though the two companies might have equivalent enterprise values. A sample case is when a company with debt were to raise money by issuing shares of stock, and then used the money to pay off the debt, this company's P/E ratio would shoot up because of the increased number of shares - although nothing about the fundamental value of the business has changed. EV / EBITDA is unaffected by capital structure as enterprise value includes the value of debt, and EBITDA is available to all investors (debt and equity) as it excludes interest payments on that debt. It is ideal for analysts and potential investors looking to compare companies within the same industry.
EV/EBITDA de empresas na Setor Health Care em NSE em comparação com HealthCare Global Enterprises
O que HealthCare Global Enterprises faz?
HealthCare Global Enterprises Limited, together with its subsidiaries, provides healthcare services focusing on cancer and fertility. The company offers cancer diagnosis and treatment services through radiation therapy, medical oncology, and surgery; and fertility treatment services, as well as reproductive medicine services, including assisted reproduction, gynecological endoscopy, and fertility preservation under the Milann brand. It also operates four multi-specialty hospitals, including three under the HCG brand in Ahmedabad, Bhavnagar, and Rajkot in the state of Gujarat, as well as one under operations and management contract in Hubli in the state of Karnataka that primarily provide cardiology, neurology, orthopedics, gastroenterology, urology, internal medicine, and pulmonary and critical care. In addition, the company offers medical diagnostic services, including scientific testing and consultancy services in the pharmaceutical and medical sector. As of March 31, 2022, the company operated 22 comprehensive cancer centers, including 1 center in Africa. The company was founded in 1989 and is based in Bengaluru, India.
Empresas com ev/ebitda semelhantes a HealthCare Global Enterprises
- KUKA AG tem EV/EBITDA de 18.17
- Dialog Semiconductor Plc tem EV/EBITDA de 18.18
- Data#3 tem EV/EBITDA de 18.18
- STAG Industrial Inc tem EV/EBITDA de 18.18
- e Bruxelles Lambert SA tem EV/EBITDA de 18.18
- Robert Half Inc tem EV/EBITDA de 18.18
- HealthCare Global Enterprises tem EV/EBITDA de 18.18
- Charmacy Pharmaceutical Co tem EV/EBITDA de 18.18
- Wolters Kluwer NV tem EV/EBITDA de 18.19
- Wolters Kluwer N.V tem EV/EBITDA de 18.19
- Cleanaway Waste Management tem EV/EBITDA de 18.19
- Hamilton Lane Inc tem EV/EBITDA de 18.19
- Mishra Dhatu Nigam tem EV/EBITDA de 18.20